Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-015804
Filing Date
2025-05-09
Accepted
2025-05-09 16:31:06
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tgtx20250331_10q.htm   iXBRL 10-Q 1406622
2 EXHIBIT 31.1 ex_758587.htm EX-31.1 12335
3 EXHIBIT 31.2 ex_758588.htm EX-31.2 12679
4 EXHIBIT 32.1 ex_758589.htm EX-32.1 5745
5 EXHIBIT 32.2 ex_758590.htm EX-32.2 6062
  Complete submission text file 0001437749-25-015804.txt   6308814

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20250331.xsd EX-101.SCH 54502
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20250331_cal.xml EX-101.CAL 42235
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20250331_def.xml EX-101.DEF 380024
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20250331_lab.xml EX-101.LAB 333147
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20250331_pre.xml EX-101.PRE 405522
70 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20250331_10q_htm.xml XML 799467
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 25930976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)